WBA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (
NASDAQWBA) common stock between April 2, 2020 and January 16, 2025, inclusive (the “Class Period”), have until March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens and certain of Walgreens’ top current and former executives with violations of the Securities Exchange Act of 1934.
Deadline to Lead in Securities Fraud Lawsuit Against Walgreens Boots Alliance, Inc. (WBA) is March 31, 2025 - Contact Kaplan Fox & Kilsheimer LLPNEW YORK - February 4, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (
NASDAQWBA) on behalf of investors that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025 (the “Class Period”).
Walgreens Marks One-Year Anniversary of Deans Advisory Council, Driving Progress in Addressing Pharmacy Industry Challenges
Today marks a milestone for Walgreens as it looks back on the progress made over the last year since the launch of the Walgreens Deans Advisory Council, formed with the goal of enhancing the pharmacy profession and advancing solutions to attract, recruit and create a dynamic workplace for current and future pharmacists.
Walgreens Boots Alliance, Inc. Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against WBASAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Walgreens Boots Alliance, Inc. (
NYSEWBA) common stock between April 2, 2020 and January 16, 2025. Walgreens operates as a healthcare, pharmacy, and retail company in the U.S., the United Kingdom, Germany, and internationally.
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (
NASDAQWBA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Walgreens Boots Alliance, Inc. (WBA) - Deadline is March 31, 2025NEW YORK - February 3, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (
NASDAQWBA) on behalf of investors that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025 (the “Class Period”).
Rosen Law Firm Urges Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of common stock of Walgreens Boots Alliance, Inc. (
NASDAQWBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”). The lawsuit states that Walgreens “operates as a healthcare, pharmacy, and retail company” in the U.S., and internationally.
WALGREEN BOOTS ALLIANCE, INC. (NASDAQ: WBA) INVESTOR ALERT: Investors With Large Losses in Walgreens Boots Alliance, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (
NASDAQWBA) between April 2, 2020 and January 16, 2025, inclusive.
Walgreens Boots Alliance Suspends Quarterly Dividend as Company Continues Disciplined Execution Against Strategic Priorities
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors is suspending the company’s cash dividend historically paid to stockholders on a quarterly basis, as management continues to evaluate and refine its capital allocation policy consistent with the company’s broader long-term turnaround efforts.
Hanley Investment Group Arranges Sale of New Construction 9,000 SF Multi-Tenant Pad at Anatolia Marketplace in Rancho Cordova, Calif., for $6.08 MillionRANCHO CORDOVA, Calif. - Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the sale of a new construction, 9,000-square-foot multi-tenant retail pad, Shops II, at the new Anatolia Marketplace shopping center in Rancho Cordova, California, an affluent suburb in the Sacramento metro area. The sale price was $6.08 million.
Rosen Law Firm Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation – WBA
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (
NASDAQWBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public.
INVESTIGATION ALERT (NASDAQ: WBA): DiCello Levitt LLP Is Investigating Investor Claims Against Walgreens Boots Alliance, Inc. and Encourages WBA Investors with Losses to Contact the FirmSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (
NASDAQWBA) violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors.
Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2025, which ended November 30, 2024.
Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Friday, January 10, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET.
The Boulder Group Arranges Sale of Net Leased Goodwill in the West Palm Beach MSAThe Boulder Group, a net leased investment brokerage firm completed the sale of a single tenant Goodwill located at 3535 9th Street Southwest in Vero Beach, Florida for $5,030,000.
Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research
With a history of more than 120 years serving communities across the country, Walgreens prides itself in being a trusted retail pharmacy partner for more than 9 million patients and customers it serves each day. Walgreens is amplifying its commitment to its patients and partners through the formation of the Walgreens Clinical Trials Patient Advisory Board. Since its launch in June 2022, the Walgreens Clinical Trials team has reached more than 7 million patients to potentially recruit into sponsor-led clinical trials. As the team continues expanding its scope and raising awareness about the importance of community-centered clinical research, the Patient Advisory Board members will offer key patient insights that are an invaluable resource to the delivery and advancement of clinical trials.
Nearly a Third of Americans Worry About Missing a Holiday Event Due to Illness
Staying healthy during the holiday season isn’t an easy task. According to a recent survey from Walgreens, 47 percent of Americans have missed a holiday event in recent years due to unexpected illness and nearly one in three are worried about it happening again this year.
